A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

Clinical trial NCT05355402 · COMPLETED

Trial details

NCT number: NCT05355402
Sponsor: Ionis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertriglyceridemia Atherosclerotic Cardiovascular Disease Severe Hypertriglyceridemia

Start date: 2022-05-09
Primary completion: 2023-03-22
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.